In its Social Security Financing Bill, the government plans to reduce health insurance reimbursements in order to earn 1.5 billion euros. The reimbursement of certain drugs could therefore well be in his sights.
To identify those which cost the most public finances, The world analyzed the Open Medic database, which lists information on reimbursable drugs. We learn that the first 10 drugs reimbursed by Social Security in 2016 cost him more than 2.5 billion euros.
Doliprane in 8th position
It is Humira, an anti-inflammatory drug prescribed to treat certain diseases such as rheumatoid arthritis, which leads the most reimbursed drugs with an invoice of 460 million euros. It is true that a month of treatment with this drug costs 815 euros.
Next, on this podium are the drugs that cost the most in reimbursement two molecules for the Macular degeneration (AMD): the Lucentis with an invoice of 322 million euros and the Eylea with a cost to Social Security of 259 million euros. Following in the list:
4. Crestor, anti-cholesterol, 240 million euros
5. Enbrel, anti-inflammatory, 235 million euros
6. Lantus, insulin, 225 million euros
7. Xarelto, anticoagulant, 216 million euros
8. Doliprane, analgesic, 202 million euros
9. Glivec, for rare leukaemias, 190 million euros
10. Aranesp renal failure, 175 million euros
Read also :
Drug sales up slightly
Generic drugs are gaining ground
